G.O.2 von Kreissl, M, Sandaradura, S.A, Dowling, J.J, Kostyukova, A.S, Moroz, N, Quinlan, K.G, Lehtokari, V, Ravenscroft, G, Todd, E.J, Ceyhan-Birsoy, O, Gokhin, D.S, Maluenda, J, Lek, M, Nolent, F, Pappas, C.T, Novak, S.M, D’Amico, A, Malfatti, E, Thomas, B.P, Gabriel, S.B, Gupta, N, Daly, M.J, Ilkovski, B, Houweling, P.J, Swanson, L.C, Brownstein, C.A, Gupta, V.A, Medne, L, Shannon, P, Flisberg, A, Holmberg, E, den Bergh, P. Van, Lapunzina, P, Waddell, L.B, Sloboda, D.D, Bertini, E, Chitayat, D, Telfer, W.R, Laquerrière, A, Gregorio, C.C, Ottenheijm, C.A.C, Bönnemann, C.G, Pelin, K, Beggs, A.H, Hayashi, Y.K, Romero, N.B, Laing, N.G, Nishino, I, Wallgren-Pettersson, C, Melki, J, Fowler, V.M, MacArthur, D.G, North, K.N, Clarke, N.F

Volltext

G.O.2: Mutations in LMOD3 cause severe nemaline myopathy by disrupting thin filament organisation in skeletal muscle von Kreissl, M., Sandaradura, S.A., Dowling, J.J., Kostyukova, A.S., Moroz, N., Quinlan, K.G., Lehtokari, V., Ravenscroft, G., Todd, E.J., Ceyhan-Birsoy, O., Gokhin, D.S., Maluenda, J., Lek, M., Nolent, F., Pappas, C.T., Novak, S.M., D’Amico, A., Malfatti, E., Thomas, B.P., Gabriel, S.B., Gupta, N., Daly, M.J., Ilkovski, B., Houweling, P.J., Swanson, L.C., Brownstein, C.A., Gupta, V.A., Medne, L., Shannon, P., Flisberg, A., Holmberg, E., den Bergh, P. Van, Lapunzina, P., Waddell, L.B., Sloboda, D.D., Bertini, E., Chitayat, D., Telfer, W.R., Laquerrière, A., Gregorio, C.C., Ottenheijm, C.A.C., Bönnemann, C.G., Pelin, K., Beggs, A.H., Hayashi, Y.K., Romero, N.B., Laing, N.G., Nishino, I., Wallgren-Pettersson, C., Melki, J., Fowler, V.M., MacArthur, D.G., North, K.N., Clarke, N.F.

Volltext